CureVac N.V.: Navigating the Frontiers of mRNA Therapeutics – A Tapestry of Innovation, AI Synergy, and Global Collaboration
In the realm of cutting-edge biopharmaceutical research, CureVac N.V. stands as a beacon of innovation. Founded in 2000 in Tübingen, Germany, by visionaries such as Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung, and Hans-Georg Rammensee, CureVac has emerged as a trailblazer in the development of therapies based on messenger…